Revolutionizing Mental Healthcare: Cybin Inc. to Present at 2025 Milken Institute Future of Health Summit
Update: 2025-11-03
Description
Cybin Inc., a Phase 3 clinical-stage neuropsychiatry company, will have its Chief Medical Officer, Amir Inamdar, speak at the upcoming 2025 Milken Institute Future of Health Summit in Washington, D.C. The company is dedicated to transforming mental healthcare through innovative treatment options like CYB003 for major depressive disorder and CYB004 for generalized anxiety disorder. Operating in multiple countries since its founding in 2019, Cybin is at the forefront of advancing mental health treatments.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
